For patients with CVID, the most sensitive parameters relative to controls may be the percentage of PD-1 and CD86 on all lymphocyte subpopulations tested, as well as CD8+ CTLA-4+ and CD4+ CD200+ and the serum concentration of all molecules tested. This evidence concerns the gene CTLA4 and common variable immunodeficiency.